Aurobindo Pharma Limited (AUROPHARMA) Q2 FY23 Earnings Concall Transcript
● Nov 13, 2022
Aurobindo Pharma Limited (NSE: AUROPHARMA) Q2 FY23 Earnings Concall dated Nov. 13, 2022 Corporate Participants: Deepti Thakur — Investor Relations Santhanam Subramanian — Chief...
